BR100 Increased By (0.01%)
BR30 Decreased By (-1.15%)
KSE100 Increased By (0.09%)
KSE30 Decreased By (-0.05%)
AGHA 6.02 Decreased By ▼ -0.03 (-0.5%)
BECO 3.81 Decreased By ▼ -0.02 (-0.52%)
BML 56.44 Decreased By ▼ -1.89 (-3.24%)
BOP 28.10 Decreased By ▼ -0.25 (-0.88%)
CNERGY 12.28 Decreased By ▼ -1.36 (-9.97%)
CSIL 5.29 Increased By ▲ 0.08 (1.54%)
FCCL 53.81 Increased By ▲ 1.53 (2.93%)
FFL 12.80 Decreased By ▼ -0.10 (-0.78%)
FNEL 1.12 Decreased By ▼ -0.01 (-0.88%)
KEL 5.64 Decreased By ▼ -0.15 (-2.59%)
KOSM 5.38 Decreased By ▼ -0.13 (-2.36%)
LOTCHEM 23.55 Decreased By ▼ -0.34 (-1.42%)
MLCF 91.96 Increased By ▲ 1.45 (1.6%)
NBP 162.24 Increased By ▲ 2.52 (1.58%)
NCPL 48.91 Decreased By ▼ -0.69 (-1.39%)
NPL 50.51 Decreased By ▼ -1.29 (-2.49%)
OGDC 301.68 Decreased By ▼ -5.10 (-1.66%)
PACE 9.13 Decreased By ▼ -0.02 (-0.22%)
PAEL 31.81 Decreased By ▼ -0.52 (-1.61%)
PIBTL 12.78 Decreased By ▼ -0.15 (-1.16%)
PPL 212.06 Decreased By ▼ -1.87 (-0.87%)
PRL 87.26 Decreased By ▼ -9.70 (-10%)
PTC 43.96 Decreased By ▼ -1.23 (-2.72%)
SSGC 22.86 Increased By ▲ 0.33 (1.46%)
TBL 8.91 Decreased By ▼ -0.11 (-1.22%)
TELE 6.44 Decreased By ▼ -0.28 (-4.17%)
TPL 24.09 Decreased By ▼ -1.82 (-7.02%)
TPLP 12.16 Decreased By ▼ -0.44 (-3.49%)
TREET 23.50 Increased By ▲ 0.04 (0.17%)
TRG 51.87 Decreased By ▼ -0.09 (-0.17%)
World

CVS to offer three over-the-counter COVID-19 tests for use at home

  • With schools and offices seeking to reopen as the country steps up its COVID-19 vaccination drive, pharmacies are boosting their offering of tests.
  • CVS said it was offering tests from Australian diagnostic test maker Ellume, Abbott Laboratories and LabCorp that do not require a prescription and can be used by individuals with or without symptoms.
Published Updated
By

CVS Health Corp said on Monday it would offer three over-the-counter COVID-19 tests at its drugstores as well as online, expanding access to home testing in the United States.

With schools and offices seeking to reopen as the country steps up its COVID-19 vaccination drive, pharmacies are boosting their offering of tests.

CVS said it was offering tests from Australian diagnostic test maker Ellume, Abbott Laboratories and LabCorp that do not require a prescription and can be used by individuals with or without symptoms.

Abbott's BinaxNOW antigen self-test, which recently received US regulatory nod, and LabCorp's test kits are available online and at some pharmacy stores, CVS said.

Separately, Abbott said its test would also be available at Walgreens Boots Alliance Inc and Walmart Inc.

Walmart will sell the test online and in stores for $19.88 per kit, while Walgreens said the test can initially be purchased online and in-store later this week.

Walgreens has also been selling LabCorp's test kits since early this month.

CVS is the first drug retailer to offer Ellume's test, the company said, adding the test will be available in select pharmacy locations in Rhode Island and Massachusetts from this week, and at CVS.com and most pharmacy stores by the end of May.

Ellume and Abbott's tests can deliver results in 15 minutes, while LabCorp's test gives results in one or two days.

Comments

Comments are closed for this article.